Efficacy & safety data
Discover how Seretide Evohaler is able to help to control the symptoms of asthma and reduce exacerbations.
Not a healthcare professional? Visit our Public site
Not a healthcare professional? Visit our Public site
has been added to your basket
59
Seretide Evohaler is over £5 cheaper than Fostair at medium dose1,2
For the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting β2 agonist
OR
Patients already adequately controlled on both inhaled corticosteroid and long-acting β2 agonist
Seretide Evohaler comes in three different doses, allowing flexibility of dosing for your patient with asthma at low, medium and high dose inhaled steroid.3
The recommended dose of Seretide Evohaler 25/50mcg, 25/125mcg and 25/250mcg is two inhalations, twice daily for patients 12 years and above.3
Seretide Evohaler 25/50mcg two inhalations, twice daily, is also licensed for use in paediatric asthma for patients 4 years and above.3
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441
Trademarks are owned by or licensed to the GSK group of companies.
March 2022 | PM-GB-FPS-WCNT-210001 (V1.0)